Previous 10 | Next 10 |
Clinical-stage Pharma company NRx Pharmaceuticals ( NASDAQ: NRXP ) announced on Friday that the FDA declined to issue its Emergency Use Authorization (EUA) for its COVID-19 therapy Zyesami (aviptadil). NRx ( NRXP ) had sought FDA nod for Zyesami targeting a subgroup of...
FDA Declines Emergency Use Authorization for ZYESAMI® (aviptadil) for subgroup of Patients with Critical COVID-19 at immediate risk of death from respiratory failure despite treatment with approved therapy, including remdesivir PR Newswire Focus is now on NRX-101 ...
NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Psychedelics, and Beyond NRx Pharmaceuticals Leaders to Present at the H.C. Wainwright & Co. 1st Annual Mental Health Conference: Neuropsychiatry, Ps...
NRx Pharmaceuticals Provides Update on Breakthrough Therapy Designation (BTD) Request for ZYESAMI® (aviptadil) PR Newswire RADNOR, Pa. , June 10, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP, NRx Pharmaceuticals), ("NRXP" or the "Comp...
NRx Pharmaceuticals (NASDAQ:NRXP) said that the company's board has appointed Seth Van Voorhees, Ph.D. as CFO and Treasurer effective June 13, 2022. Dr. Van Voorhees most recently served as CFO of PDS Biotechnology during which he completed several financing transactions in 2021. Shares are...
NRx Pharmaceuticals Appoints Seth Van Voorhees, PhD, as Chief Financial Officer and Treasurer PR Newswire RADNOR, Pa. , June 7, 2022 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP), a clinical-stage biopharmaceutical company, announced today that...
The definition of penny stocks is shares of companies trading below $5. But some of the most active traders in the stock market today focus on far cheaper issuers daily. Today we look at a few of the lowest-priced companies gaining attention. While there are many risks involved with stocks ...
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Sisacorn / Shutterstock.com Today’s price action has been otherwise bullish in the stock market. However, for shareholders in NRx Pharmaceuticals (NASDAQ: NRXP ), it’s been a rough day. At th...
Gainers: Redbox Entertainment (RDBX) +37%. Vivid Seats (SEAT) +37%. VIQ Solutions (VQS) +29%. Modine Manufacturing (MOD) +28%. Eargo (EAR) +27%. Charah Solutions (CHRA) +23%. Baozun (BZUN) +21%. Alpha Teknova (TKNO) +20%. Standard BioTools (LAB) +20%. Losers: NRx Pharmaceuticals (NRXP) -63%. ...
Gainers: Apyx Medical (APYX) +39%. Enochian Biosciences (ENOB) +17%. Concert Pharmaceuticals (CNCE) +14%. GeoVax Labs (GOVX) +14%. Liquidia (LQDA) +13%. Losers: NRx Pharmaceuticals (NRXP) -57%. Avadel Pharmaceuticals (AVDL) -44%. Nurix Therape...
News, Short Squeeze, Breakout and More Instantly...
NRX Pharmaceuticals Inc. Company Name:
NRXP Stock Symbol:
NASDAQ Market:
NRX Pharmaceuticals Inc. Website:
NRx Pharmaceuticals (NASDAQ:NRXP) to Proceed with Two New Drug Applications in 2024; NRX-101 has Been Returned to the Company for Filing PR Newswire New Drug Application (NDA) for Accelerated Approval planned for NRX-101 in people with bipolar depression and akathisia in 202...
NRx Pharmaceuticals, Inc. (Nasdaq:NRXP) to Participate in the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference on June 27, 2024 PR Newswire RADNOR, Pa. , June 20, 2024 /PRNewswire/ -- NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) ("NRx Pharmaceuticals"...
NRx Pharmaceuticals (NASDAQ:NRXP) Appoints Neuroscience, Information Technology and Medical Technology Veteran to its Board of Directors PR Newswire Dr. Dennis McBride brings extensive experience in Neuroscience and its interface with Information and Medical Technology ...